ArticleMolecular cancer therapeutics2018

Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms.

Aaron J Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.